Evidence map›Paper›PMID 35120478›Full record

ArticleBMC pulmonary medicine2022

Trajectories of hypoxemia and pulmonary mechanics of COVID-19 ARDS in the NorthCARDS dataset.

Daniel Jafari, Amir Gandomi, Alex Makhnevich, Michael Qiu, Daniel M Rolston, Eric P Gottesman, Adey Tsegaye, Paul H Mayo, Molly E Stewart, Meng Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Daniel JafariDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.
Amir GandomiFrank G Zarb School of Business at Hofstra University, Hempstead, USA.
Alex MakhnevichDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.
Michael QiuCenter for Health Innovations and Outcomes Research, Feinstein Institute for Medical Research, Manhasset, USA.
Daniel M RolstonDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.
Eric P GottesmanDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.
Adey TsegayeDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.
Paul H MayoDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.
Molly E StewartCenter for Health Innovations and Outcomes Research, Feinstein Institute for Medical Research, Manhasset, USA.
Meng ZhangCenter for Health Innovations and Outcomes Research, Feinstein Institute for Medical Research, Manhasset, USA.
Negin HajizadehDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA. Nhajizadeh@northwell.edu.ORCID http://orcid.org/0000-0002-6404-1018
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell · USFeinstein Institute for Medical Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding heterogeneity seen in patients with COVIDARDS and comparing to non-COVIDARDS may inform tailored treatments.

methodsA multidisciplinary team of frontline clinicians and data scientists worked to create the Northwell COVIDARDS dataset (NorthCARDS) leveraging over 11,542 COVID-19 hospital admissions. The data was then summarized to examine descriptive differences based on clinically meaningful categories of lung compliance, and to examine trends in oxygenation.

findingsOf the 1536 COVIDARDS patients in the NorthCARDS dataset, there were 531 (34.6%) who had very low lung compliance (< 20 ml/cmH

conclusionsThe respiratory system compliance distribution of COVIDARDS is similar to non-COVIDARDS. In some patients, there may be a relation between time to intubation and duration of high levels of supplemental oxygen treatment on trajectory of lung compliance.

Indexed as

AdultAgedAged, 80 and overBiomechanical PhenomenaCase-Control StudiesCOVID-19Disease ProgressionFemaleHumansHypoxiaLungMaleMiddle AgedRespiration, ArtificialRespiratory Distress SyndromeRespiratory Function TestsARDSCOVIDCOVID-19Pulmonary complianceRespiratory system compliance

Identifiers

PMID35120478
PMCPMC8814783
OpenAlexW4210344955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.